| Accepted Article Preview: Published ahead of advance online publication DC Deniger, A Pasetto, E Tran, MR Parkhurst, CJ Cohen, PF Robbins, ... | 1243* | 2016 |
| Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study N Barda, N Dagan, C Cohen, MA Hernán, M Lipsitch, IS Kohane, BY Reis, ... The Lancet 398 (10316), 2093-2100, 2021 | 880 | 2021 |
| Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions CJ Cohen, G Denkberg, A Lev, M Epel, Y Reiter Journal of Molecular Recognition 16 (5), 324-332, 2003 | 787 | 2003 |
| Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC … CJ Cohen, O Sarig, Y Yamano, U Tomaru, S Jacobson, Y Reiter The Journal of Immunology 170 (8), 4349-4361, 2003 | 760 | 2003 |
| TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection F Alfei, K Kanev, M Hofmann, M Wu, HE Ghoneim, P Roelli, ... Nature 571 (7764), 265-269, 2019 | 681 | 2019 |
| Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability CJ Cohen, Y Zhao, Z Zheng, SA Rosenberg, RA Morgan Cancer research 66 (17), 8878-8886, 2006 | 578 | 2006 |
| Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond CJ Cohen, YF Li, M El-Gamil, PF Robbins, SA Rosenberg, RA Morgan Cancer research 67 (8), 3898-3903, 2007 | 435 | 2007 |
| Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes CJ Cohen, JJ Gartner, M Horovitz-Fried, K Shamalov, ... The Journal of clinical investigation 125 (10), 3981-3991, 2015 | 406 | 2015 |
| Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes LA Johnson, B Heemskerk, DJ Powell, CJ Cohen, RA Morgan, ME Dudley, ... The Journal of Immunology 177 (9), 6548-6559, 2006 | 389 | 2006 |
| High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation Y Zhao, Z Zheng, CJ Cohen, L Gattinoni, DC Palmer, NP Restifo, ... Molecular Therapy 13 (1), 151-159, 2006 | 357 | 2006 |
| Simple sequence repeats in Escherichia coli: abundance, distribution, composition, and polymorphism R Gur-Arie, CJ Cohen, Y Eitan, L Shelef, EM Hallerman, Y Kashi Genome Research 10 (1), 62-71, 2000 | 321 | 2000 |
| Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging R Meir, K Shamalov, O Betzer, M Motiei, M Horovitz-Fried, R Yehuda, ... ACS nano 9 (6), 6363-6372, 2015 | 233 | 2015 |
| Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition S Yang, CJ Cohen, PD Peng, Y Zhao, L Cassard, Z Yu, Z Zheng, S Jones, ... Gene therapy 15 (21), 1411-1423, 2008 | 222 | 2008 |
| Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR CJ Cohen, Z Zheng, R Bray, Y Zhao, LA Sherman, SA Rosenberg, ... The Journal of Immunology 175 (9), 5799-5808, 2005 | 180 | 2005 |
| Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells N Himoudi, DA Morgenstern, M Yan, B Vernay, L Saraiva, Y Wu, ... The Journal of Immunology 188 (4), 1708-1716, 2012 | 161 | 2012 |
| Durable complete response from metastatic melanoma after transfer of autologous T cells recognizing 10 mutated tumor antigens TD Prickett, JS Crystal, CJ Cohen, A Pasetto, MR Parkhurst, JJ Gartner, ... Cancer immunology research 4 (8), 669-678, 2016 | 146 | 2016 |
| Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed … A Lev, G Denkberg, CJ Cohen, M Tzukerman, KL Skorecki, P Chames, ... Cancer research 62 (11), 3184-3194, 2002 | 135 | 2002 |
| Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity C Ankri, K Shamalov, M Horovitz-Fried, S Mauer, CJ Cohen The Journal of Immunology 191 (8), 4121-4129, 2013 | 123 | 2013 |
| Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene C Hsu, SA Jones, CJ Cohen, Z Zheng, K Kerstann, J Zhou, PF Robbins, ... Blood 109 (12), 5168-5177, 2007 | 122 | 2007 |
| Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity PD Peng, CJ Cohen, S Yang, C Hsu, S Jones, Y Zhao, Z Zheng, ... Gene therapy 16 (8), 1042-1049, 2009 | 119 | 2009 |
Steven A RosenbergNCIVerified email at nih.gov
